Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis

Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux

(2011) Gail E. Louw et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Role of P27-P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds

(2011) María V Bianco et al.   BMC INFECTIOUS DISEASES

Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus

(2011) Sofia Costa et al.   BMC MICROBIOLOGY

The ins and outs of Mycobacterium tuberculosis drug susceptibility testing

(2011) E.C. Böttger   CLINICAL MICROBIOLOGY AND INFECTION

A new evolutionary and pharmacokinetic–pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs

(2011) Jotam G Pasipanodya et al.   CURRENT OPINION IN PHARMACOLOGY

Efflux as a mechanism for drug resistance inMycobacterium tuberculosis: Table 1

(2011) Pedro Eduardo Almeida da Silva et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis

(2010) J. E. M. de Steenwinkel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of Ethambutol

(2010) Shashikant Srivastava et al.   JOURNAL OF INFECTIOUS DISEASES

Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection

(2010) Alimuddin Zumla et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

(2009) G. E. Louw et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators

(2009) A. Martins et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The role of efflux pumps in macrolide resistance in Mycobacterium avium complex

(2009) Liliana Rodrigues et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance

(2009) Indra L. Bergval et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation

(2009) B. Springer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous Drugs

(2009) Anuj Kumar Gupta et al.   Microbial Drug Resistance

Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli

(2009) Laura Paixão et al.   Journal of Biological Engineering

Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates

(2008) R. Vijdea et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis

(2008) L. Rodrigues et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multidrug-Resistant Tuberculosis in Lisbon, Portugal: A Molecular Epidemiological Perspective

(2008) João Perdigão et al.   Microbial Drug Resistance